Literature DB >> 17559276

Phosphatidylinositol mannoside ether analogues: syntheses and interleukin-12-inducing properties.

Gary D Ainge1, Natalie A Parlane, Michel Denis, Blake S Dyer, Andrea Härer, Colin M Hayman, David S Larsen, Gavin F Painter.   

Abstract

Phosphatidylinositol mannosides (PIMs) isolated from mycobacteria have been identified as an important class of glycolipids with significant immune modulating properties. We present here the syntheses of phosphatidylinositol dimannoside ether analogues 2 and 3 and evaluate their interleukin-12 (IL-12)-inducing properties along with dipalmitoyl PIM2 (1) in an in vitro bovine dendritic cell assay. Both synthetic PIM analogues and synthetic dipalmitoyl PIM2 (1) were effective at enhancing IL-12 production by immature bovine dendritic cells. Unexpectedly, ether analogue 2 was significantly more active than dipalmitoyl PIM2 (1) which indicates that modified PIM compounds can be strongly immunoactive and may have significant adjuvant activities.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17559276     DOI: 10.1021/jo070639m

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  6 in total

1.  Synthesis and Toll-like receptor 4 (TLR4) activity of phosphatidylinositol dimannoside analogues.

Authors:  Gary D Ainge; William John Martin; Benjamin J Compton; Colin M Hayman; David S Larsen; Sung-Il Yoon; Ian A Wilson; Jacquie L Harper; Gavin F Painter
Journal:  J Med Chem       Date:  2011-10-05       Impact factor: 7.446

2.  Highly purified mycobacterial phosphatidylinositol mannosides drive cell-mediated responses and activate NKT cells in cattle.

Authors:  Chris Pirson; Regina Engel; Gareth J Jones; Thomas Holder; Otto Holst; H Martin Vordermeier
Journal:  Clin Vaccine Immunol       Date:  2014-12-10

3.  Enhanced protection against bovine tuberculosis after coadministration of Mycobacterium bovis BCG with a Mycobacterial protein vaccine-adjuvant combination but not after coadministration of adjuvant alone.

Authors:  D Neil Wedlock; Michel Denis; Gavin F Painter; Gary D Ainge; H Martin Vordermeier; R Glyn Hewinson; Bryce M Buddle
Journal:  Clin Vaccine Immunol       Date:  2008-03-12

4.  Synthesis of a tristearoyl lipomannan via preactivation-based iterative one-pot glycosylation.

Authors:  Jian Gao; Zhongwu Guo
Journal:  J Org Chem       Date:  2013-12-03       Impact factor: 4.354

5.  Total synthesis of tetraacylated phosphatidylinositol hexamannoside and evaluation of its immunomodulatory activity.

Authors:  Pratap S Patil; Ting-Jen Rachel Cheng; Medel Manuel L Zulueta; Shih-Ting Yang; Larry S Lico; Shang-Cheng Hung
Journal:  Nat Commun       Date:  2015-06-03       Impact factor: 14.919

6.  Synthesis of a miniature lipoarabinomannan.

Authors:  Jian Gao; Guochao Liao; Lizhen Wang; Zhongwu Guo
Journal:  Org Lett       Date:  2014-01-21       Impact factor: 6.005

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.